OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
6869$1396.0058

6869.T

Medical Equipment, Supplies & DistributionVerified

The company maintains a strong liquidity position, with a current ratio of 2.97 and cash and equivalents amounting to 89.57 billion JPY. Its debt-to-equity ratio is 0.14, indicating a conservative capital structure with limited leverage. The company's price-to-book ratio is 1.87, and its price-to-tangible-book ratio is also 1.87, suggesting that the market values the company's tangible assets at a premium relative to its book value. In terms of profitability, the company's return on equity (ROE) is 11.57%, and its return on assets (ROA) is 8.07%, both of which are strong indicators of efficient capital utilization and asset management. The company's operating income of 87.06 billion JPY and net income of 53.67 billion JPY reflect a healthy margin structure, with a gross profit of 271.98 billion JPY on total revenue of 508.64 billion JPY. The company's revenue is concentrated in the healthcare services and equipment industry, with no disclosed geographic diversification or segment breakdown provided in the available data. This lack of segmentation makes it difficult to assess the geographic or product-specific exposure of the company's revenue. Looking ahead, the company is projected to maintain a stable growth trajectory, with no specific numeric deltas provided in the outlook. However, the company's operating cash flow of 88.25 billion JPY and free cash flow of 24.20 billion JPY suggest a solid cash generation capability, which supports ongoing operations and potential reinvestment. The company's risk profile is characterized by low liquidity and dilution risks, with no immediate filing-based liquidity or dilution flags detected. The dilution potential is also low, and the company has not made any recent equity issuances or disclosed any dilutive events in the available data. Recent events, including filings and transcripts, have not been disclosed in the available data. Analysts have provided a mean price target of 1,859.33 JPY and a median price target of 1,650.00 JPY, with a mean recommendation of 2.41, indicating a generally positive outlook from the investment community.

30-day price · 6869-4.00 (-0.3%)
Low$1246.00High$1464.50Close$1381.50As of28 May, 00:00 UTC
Profile
Company6869.T
Ticker6869.T
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.

Classification. The company is classified under the industry "Medical Equipment, Supplies & Distribution" within the business sector "Healthcare Services & Equipment," with a classification confidence of 0.92.

The company maintains a strong liquidity position, with a current ratio of 2.97 and cash and equivalents amounting to 89.57 billion JPY. Its debt-to-equity ratio is 0.14, indicating a conservative capital structure with limited leverage. The company's price-to-book ratio is 1.87, and its price-to-tangible-book ratio is also 1.87, suggesting that the market values the company's tangible assets at a premium relative to its book value. In terms of profitability, the company's return on equity (ROE) is 11.57%, and its return on assets (ROA) is 8.07%, both of which are strong indicators of efficient capital utilization and asset management. The company's operating income of 87.06 billion JPY and net income of 53.67 billion JPY reflect a healthy margin structure, with a gross profit of 271.98 billion JPY on total revenue of 508.64 billion JPY. The company's revenue is concentrated in the healthcare services and equipment industry, with no disclosed geographic diversification or segment breakdown provided in the available data. This lack of segmentation makes it difficult to assess the geographic or product-specific exposure of the company's revenue. Looking ahead, the company is projected to maintain a stable growth trajectory, with no specific numeric deltas provided in the outlook. However, the company's operating cash flow of 88.25 billion JPY and free cash flow of 24.20 billion JPY suggest a solid cash generation capability, which supports ongoing operations and potential reinvestment. The company's risk profile is characterized by low liquidity and dilution risks, with no immediate filing-based liquidity or dilution flags detected. The dilution potential is also low, and the company has not made any recent equity issuances or disclosed any dilutive events in the available data. Recent events, including filings and transcripts, have not been disclosed in the available data. Analysts have provided a mean price target of 1,859.33 JPY and a median price target of 1,650.00 JPY, with a mean recommendation of 2.41, indicating a generally positive outlook from the investment community.
Key takeaways
  • The company has a strong liquidity position with a current ratio of 2.97 and significant cash reserves.
  • The company's ROE of 11.57% and ROA of 8.07% indicate efficient capital and asset utilization.
  • The company's conservative capital structure, with a debt-to-equity ratio of 0.14, suggests limited financial risk.
  • Analysts have a generally positive outlook, with a mean price target of 1,859.33 JPY and a median price target of 1,650.00 JPY.
  • --
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$508.64B
Gross profit$271.98B
Operating income$87.06B
Net income$53.67B
R&D
SG&A
D&A
SBC
Operating cash flow$88.25B
CapEx-$49.96B
Free cash flow$24.20B
Total assets$665.27B
Total liabilities$201.49B
Total equity$463.78B
Cash & equivalents$89.57B
Long-term debt$65.45B
Valuation
Market price$1396.00
Market cap$867.59B
Enterprise value$843.47B
P/E16.2
Reported non-GAAP P/E
EV/Revenue1.7
EV/Op income9.7
EV/OCF9.6
P/B1.9
P/Tangible book1.9
Tangible book$463.78B
Net cash$24.12B
Current ratio3.0
Debt/Equity0.1
ROA8.1%
ROE11.6%
Cash conversion1.6%
CapEx/Revenue-9.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
Metric6869Activity
Op margin17.1%3.9% medp25 -31.3% · p75 14.4%top quartile
Net margin10.6%2.4% medp25 -30.5% · p75 11.1%above median
Gross margin53.5%46.7% medp25 28.2% · p75 63.1%above median
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-9.8%-4.8% medp25 -11.6% · p75 -2.4%below median
Debt / equity14.0%17.9% medp25 2.7% · p75 52.2%below median
Observations
IR observations
Mean price target1,859.33 JPY
Median price target1,650.00 JPY
High price target3,300.00 JPY
Low price target1,300.00 JPY
Mean recommendation2.41 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count8.00
Hold count8.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate68.26 JPY
Last actual EPS86.07 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-06 21:43 UTC#c8d0fc97
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 02:24 UTCJob: f0d8df38